Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emerson Delacroix has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Ken Resnicow

    School of Public Health, University of Michigan, Ann Arbor, Michigan, USA

    7 shared publications
  • Corinna Koebnick

    Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States

    3 shared publications
  • Erika N. Hanson

    Department of Internal Medicine University of Michigan School of Medicine Ann Arbor Michigan USA

    3 shared publications
  • Jennifer J. Griggs

    Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI 48109, USA; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI 48109, USA; Department of Health Management and Policy, University of Michigan, Ann Arbor, MI 48109, USA

    3 shared publications
  • Ken Resnicow

    Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN 55455, USA

    3 shared publications
  • Margo Sidell

    Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA

    3 shared publications

Latest Publications

  • Open Access

    Evaluating the Effectiveness of the Motivational Interviewing–Based Wellness Coaching for Kids and Families (WC4K) Program in Pediatric Obesity Care: Protocol for a Cluster Randomized Pragmatic Trial

    by Corinna Koebnick, Margo Sidell, Jessica D Vallejo, Xia Li, Emerson Delacroix, Deborah Young, Poornima Kunani, Ken Resnicow

    Background: The increasing prevalence of severe obesity among youth and the early onset of comorbidities highlight the urgent need for effective solutions to support behavior and lifestyle changes. Motivational interviewing (MI), a client-centered counseling technique, has shown promise in improving obesity-related outcomes and is now recommended by the American Academy of Pediatrics as a key component of behavioral interventions for children with overweight and obesity. Objective: This study aimed to describe the design and baseline characteristics of the Wellness Coaching for Kids and Families (WC4K) program, an MI-based behavioral health intervention integrated into pediatric primary care within a large integrated health care system. This trial aims to inform broader implementation strategies for other health care systems. Methods: We are conducting a cluster randomized pragmatic trial across 50 pediatric clinics within Kaiser Permanente Southern California. Clinics were randomized to either the intervention arm (n=24, 48.00%) or the usual care arm (n=26, 52.00%), targeting children aged between 3 and 8 years with overweight or obesity. Pediatricians in intervention clinics received MI training and referred families to centralized health coaches for tailored telephone counseling. Key behavioral targets include increased fruit and vegetable intake, reduced consumption of sugar-sweetened beverages, increased physical activity, and reduced screen time. The primary outcome is a change in BMI-for-age, measured as relative distance from the median using electronic medical record data. Secondary outcomes include parent-reported behavior change indicators. Results: The source population includes 150,482 children from clinics serving predominantly low-income and racial and ethnic minority populations. After randomization, intervention and control clinics were similar in demographics (standardized mean differences <0.2 for key variables), with 77,481 (51.49%) children in the WC4K intervention clinics and 73,001 (48.51%) children in the control clinics. In the total clinic population, 36.58% (55,052/150,482) of the children were overweight or with obesity. Enrollment started in fall 2022, study results are expected in spring 2027. Conclusions: If the trial results indicate success in reducing BMI and improving health behaviors, WC4K may offer a scalable and sustainable model for integrating behavioral health coaching into pediatric primary care. By leveraging MI-trained pediatricians and centralized health coaching, WC4K has the potential to facilitate meaningful lifestyle changes in children with overweight or obesity. Trial Registration: ClinicalTrials.gov NCT05143697; https://clinicaltrials.gov/study/NCT05143697 International Registered Report Identifier (IRRID): DERR1-10.2196/78792

  • Open Access

    Quantifying the role of communication in recruitment status outcomes for a clinical trial on genetic testing uptake

    by Arianna Morel, Emerson Delacroix, John D. Rice, Sarah Austin, Erika Koeppe, Erika N. Hanson, Jennifer J. Griggs, Elena Martinez Stoffel, Ken Resnicow

  • Parental Concerns About Child Disordered Eating Among Youth With High Weights Participating in a Motivational Interviewing-Based Behavioral Intervention

    by Lenora P. Goodman, Emerson Delacroix, Sarah McNally, Ken Resnicow, Shannon Considine, Jennifer Steffes, Donna Harris, Heide Woo, Melissa S. Stockwell, Kendrin R. Sonneville

  • Open Access

    Evaluating the Effectiveness of the Motivational Interviewing–Based Wellness Coaching for Kids and Families (WC4K) Program in Pediatric Obesity Care: Protocol for a Cluster Randomized Pragmatic Trial (Preprint)

    by Corinna Koebnick, Margo Sidell, Jessica D Vallejo, Xia Li, Emerson Delacroix, Deborah Young, Poornima Kunani, Ken Resnicow

    BACKGROUND The increasing prevalence of severe obesity among youth and the early onset of comorbidities highlight the urgent need for effective solutions to support behavior and lifestyle changes. Motivational interviewing (MI), a client-centered counseling technique, has shown promise in improving obesity-related outcomes and is now recommended by the American Academy of Pediatrics as a key component of behavioral interventions for children with overweight and obesity. OBJECTIVE This study aimed to describe the design and baseline characteristics of the Wellness Coaching for Kids and Families (WC4K) program, an MI-based behavioral health intervention integrated into pediatric primary care within a large integrated health care system. This trial aims to inform broader implementation strategies for other health care systems. METHODS We are conducting a cluster randomized pragmatic trial across 50 pediatric clinics within Kaiser Permanente Southern California. Clinics were randomized to either the intervention arm (n=24, 48.00%) or the usual care arm (n=26, 52.00%), targeting children aged between 3 and 8 years with overweight or obesity. Pediatricians in intervention clinics received MI training and referred families to centralized health coaches for tailored telephone counseling. Key behavioral targets include increased fruit and vegetable intake, reduced consumption of sugar-sweetened beverages, increased physical activity, and reduced screen time. The primary outcome is a change in BMI-for-age, measured as relative distance from the median using electronic medical record data. Secondary outcomes include parent-reported behavior change indicators. RESULTS The source population includes 150,482 children from clinics serving predominantly low-income and racial and ethnic minority populations. After randomization, intervention and control clinics were similar in demographics (standardized mean differences <0.2 for key variables), with 77,481 (51.49%) children in the WC4K intervention clinics and 73,001 (48.51%) children in the control clinics. In the total clinic population, 36.58% (55,052/150,482) of the children were overweight or with obesity. Enrollment started in fall 2022, study results are expected in spring 2027. CONCLUSIONS If the trial results indicate success in reducing BMI and improving health behaviors, WC4K may offer a scalable and sustainable model for integrating behavioral health coaching into pediatric primary care. By leveraging MI-trained pediatricians and centralized health coaching, WC4K has the potential to facilitate meaningful lifestyle changes in children with overweight or obesity. CLINICALTRIAL ClinicalTrials.gov NCT05143697; https://clinicaltrials.gov/study/NCT05143697 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/78792

  • Open Access

    Clinician Recommendation for Hereditary Genetic Testing in Participants at Increased Risk for Hereditary Cancer

    by Emerson Delacroix, Sarah Austin, John D. Rice, Elena Martinez Stoffel, Erika Koeppe, Jennifer J. Griggs, Ken Resnicow

    Background: Despite clinical utility in managing hereditary cancers, genetic testing (GT) remains underutilized. While barriers include knowledge gaps and cost, clinician recommendation is a major driver of GT uptake, with rates varying by cancer type and family cancer history documentation. Methods: Adult participants (≥18 years) were recruited through multiple sources to complete a cancer family history survey for a larger intervention trial. Participants with personal or family history indicating increased hereditary cancer risk who had not undergone GT (N = 3001) were invited to complete a baseline survey. Multivariable logistic regression was used to analyze associations between demographics and cancer history by receipt of a clinician recommendation for GT. Results: Among 784 respondents, most were White (84.6%), female (58.4%), and over age 51 (75.3%), with 58.2% reporting a diagnosis of cancer. Only 14.0% reported receiving a clinician recommendation for GT, with lower recommendation rates among younger adults (20.1%), those reporting no financial stress (10.7%), and those with higher education (12.0%). Multivariate analysis showed participants who did not report financial stress (p = 0.049) were less likely to receive a recommendation. Discussion: These findings highlight disparities in GT recommendation by clinicians. Increased clinician education about indications for GT, the implementation of electronic medical record tools to facilitate the identification of patients with guideline-concordant personal and/or biological-relative cancer history, and patient-facing interventions could standardize the dissemination of recommendations for GT. Conclusions: Future efforts that focus on increasing clinician education and electronic decision support should identify individuals with personal and/or biological-relative cancer history meeting criteria for GT.


  • Open Access

    Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing

    by Sarah Austin, Erika N. Hanson, Emerson Delacroix, Elizabeth Bacon, John Rice, Lynette Hammond Gerido, Elizabeth Rizzo, Versha Pleasant, Elena M. Stoffel, Jennifer J. Griggs, et al.

    Genetic testing for hereditary cancer syndromes can provide lifesaving information allowing for individualized cancer screening, prevention, and treatment. However, the determinants, both barriers and motivators, of genetic testing intention are not well described. A survey of barriers and motivators to genetic testing was emailed to adult patients eligible for genetic testing based on cancer diagnosis who previously have not had genetic testing (n = 201). Associations between barriers/motivators with testing intention and confidence were examined first by correlation followed by multivariable linear regression model holding constant potential covariates. Seven barrier items from two domains (logistics and genetic testing knowledge) were found to significantly negatively correlate with genetic testing intention. Unexpectedly, three barrier items had significant positive correlation with genetic testing intention; these were related to family worry (passing a condition on to future generations) and testing knowledge (needing more information on the genetic testing process and what it has to offer). Ten barrier items had significant negative correlation with confidence to get a genetic test and encompassed four domains: stigma, insurance/genetic discrimination, knowledge, and cost. All motivator items were associated with intention to get a genetic test, while none were associated with confidence. Multivariable analysis yielded six total barriers (five from the knowledge domain, one from cost domain) and two motivators (relieved to know and treatment impact) that were significantly associated with genetic testing intention or confidence when controlling for demographic characteristics. These findings indicate the need for tailored interventions to amplify motivating factors and counter‐message barriers to enhance patient motivation and confidence to undergo testing.


  • Open Access

    Controlling Hypertension through Education and Coaching in Kidney Disease (CHECK-D): protocol of a cluster randomised controlled trial

    by Julie A Wright Nunes, Ken Resnicow, Caroline Richardson, Diane Levine, Eve Kerr, Rajiv Saran, Brenda Gillespie, Jennifer Bragg-Gresham, Emerson L Delacroix, Shannon Considine, et al.

    Introduction Chronic kidney disease (CKD) affects 30 million Americans. Early management focused on blood pressure (BP) control decreases cardiovascular morbidity and mortality. Less than 40% of patients with CKD achieve recommended BP targets due to many barriers. These barriers include a lack of understanding of the implications of their diagnosis and how to optimise their health. This cluster randomised control trial hypothesises that the combination of early primary care CKD education, and motivational interviewing (MI)-based health coach support, will improve patient behaviours aligned with BP control by increasing patient knowledge, self-efficacy and motivation. The results will aid in sustainable interventions for future patient-centric education and coaching support to improve quality and outcomes in patients with CKD stages 3–5. Outcomes in patients with CKD stages 3–5 receiving the intervention will be compared with similar patients within a control group. Continuous quality improvement (CQI) and systems methodologies will be used to optimise resource neutrality and leverage existing technology to support implementation and future dissemination. The innovative approach of this research focuses on the importance of a multidisciplinary team, including off-site patient coaching, that can intervene early in the CKD care continuum by supporting patients with education and coaching. Methods and analysis We will test impact of BP control when clinician-delivered education is followed by 12 months of MI-based health coaching. We will compare outcomes in 350 patients with CKD stages 3–5 between intervention and control groups in primary care. CQI and systems methodologies will optimise education and coaching for future implementation and dissemination. Ethics and dissemination This study was approved by the University of Michigan Institutional Review Boards (IRBMED) HUM00136011, HUM00150672 and SITE00000092 and the results of the study will be published on ClinicalTrials.gov, in peer-reviewed journals, as well as conference abstracts, posters and presentations. Trial registration number NCT04087798.


  • Open Access

    Psychosocial factors impacting barriers and motivators to cancer genetic testing

    by Erika N. Hanson, Emerson Delacroix, Sarah Austin, Grant Carr, Kelley M. Kidwell, Elizabeth Bacon, Lynette Hammond Gerido, Jennifer J. Griggs, Elena M. Stoffel, Ken Resnicow

    Background: Only a small proportion of patients who qualify for clinical genetic testing for cancer susceptibility get testing. Many patient‐level barriers contribute to low uptake. In this study, we examined self‐reported patient barriers and motivators for cancer genetic testing.Methods: A survey comprised of both new and existing measures related to barriers and motivators to genetic testing was emailed to patients with a diagnosis of cancer at a large academic medical center. Patients who self‐reported receiving a genetic test were included in these analyses (n = 376). Responses about emotions following testing as well as barriers and motivators prior to getting testing were examined. Group differences in barriers and motivators by patient demographic characteristics were examined.Results: Being assigned female at birth was associated with increased emotional, insurance, and family concerns as well as increased health benefits compared to patients assigned male at birth. Younger respondents had significantly higher emotional and family concerns compared to older respondents. Recently diagnosed respondents expressed fewer concerns about insurance implications and emotional concerns. Those with a BRCA‐related cancer had higher scores on social and interpersonal concerns scale than those with other cancers. Participants with higher depression scores indicated increased emotional, social and interpersonal, and family concerns.Conclusions: Self‐reported depression emerged as the most consistent factor influencing report of barriers to genetic testing. By incorporating mental health resources into clinical practice, oncologists may better identify those patients who might need more assistance following through with a referral for genetic testing and the response afterwards.


  • Open Access

    Motivational interviewing for genetic counseling: A unified framework for persuasive and equipoise conversations

    by Ken Resnicow, Emerson Delacroix, Gabriela Chen, Sarah Austin, Elena Stoffel, Erika N. Hanson, Lynette Hammond Gerido, Kimberly A. Kaphingst, Beverly M. Yashar, Monica Marvin, et al.

    Genetic counselors (GCs) have traditionally been trained to adopt a position of equipoise or clinical neutrality. They provide information, answer questions, address barriers, and engage in shared decision‐making, but generally, they do not prescribe a genetic test. Historically, GCs have generally been trained not to persuade the ambivalent or resistant patient. More recently, however, there has been discussion regarding when a greater degree of persuasion or directionality may be appropriate within genetic counseling (GC) and what role MI may play in this process. The role for “persuasive GC” is based on the premise that some genetic tests provide actionable information that would clearly benefit patients and families by impacting treatment or surveillance. For other tests, the benefits are less clear as they do not directly impact patient care or the benefits may be more subjective in nature, driven by patient values or psychological needs. For the former, we propose that GCs may adopt a more persuasive clinical approach while for the latter, a more traditional equipoise stance may be more appropriate. We suggest that motivational interviewing (MI) could serve as a unifying counseling model that allows GCs to handle both persuasive and equipoise encounters. For clearly beneficial tests, while directional, the MI encounter can still be non‐directive, autonomy‐supportive, and patient‐centered. MI can also be adapted for equipoise situations, for example, placing less emphasis on eliciting and strengthening change talk as that is more a behavior change strategy than a shared decision‐making strategy. The core principles and strategies of MI, such as autonomy support, evocation, open questions, reflective listening, and affirmation would apply to both persuasive and equipoise encounters. Key issues that merit discussion include how best to train GCs both during their initial and post‐graduate education.